Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein

被引：0
|
作者：
Richard B. Kirn
Christoph Wandel
Brenda Leake
Mirjana Cvetkovic
Martin F. Fromm
Peter J. Dempsey
Mark M. Roden
Frank Belas
Ajai K. Chaudhary
Dan M. Roden
Alastair J. J. Wood
Grant R. Wilkinson
机构：
[1] Vanderbilt University School of Medicine,Departments of Medicine and Pharmacology
来源：
Pharmaceutical Research | 1999年 / 16卷 / 3期
关键词：
CYP3A4; P-glycoprotein; drug transport; cytochrome P450;
D O I：
10.1023/A:1018877803319
中图分类号：
学科分类号：
摘要：
Purpose. CYP3A and P-gp both function to reduce the intracellular concentration of drug substrates, one by metabolism and the other by transmembrane efflux. Moreover, it has been serendipitously noted that the two proteins have many common substrates and inhibitors. In order to test this notion more fully, systematic studies were undertaken to determine the P-gp-mediated transport and inhibitory characteristics of prototypical CYP substrates.
引用
收藏
页码：408 / 414
页数：6
相关论文
共 50 条
  • [21] Effects of P-glycoprotein (P-GP) inhibitors on CYP3A.
    Wandel, C
    Kim, RB
    Kajiji, S
    Guengerich, FP
    Wood, AJJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 206 - 206
  • [22] Drugs as P-glycoprotein substrates, inhibitors, and inducers
    Kim, RB
    DRUG METABOLISM REVIEWS, 2002, 34 (1-2) : 47 - 54
  • [23] Detergents as intrinsic P-glycoprotein substrates and inhibitors
    Li-Blatter, Xiaochun
    Nervi, Pierluigi
    Seelig, Anna
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2009, 1788 (10): : 2335 - 2344
  • [24] Rapid identification of P-glycoprotein substrates and inhibitors
    Chang, Cheng
    Bahadduri, Praveen M.
    Polli, James E.
    Swaan, Peter W.
    Ekins, Sean
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (12) : 1976 - 1984
  • [25] Inhibition of CYP3A mediated metabolism and P-glycoprotein mediated transport by herbal supplements
    Hay, E
    Cummins, CL
    Simonsson, P
    Unger, M
    Benet, LZ
    Christians, U
    Jacobsen, W
    DRUG METABOLISM REVIEWS, 2002, 34 : 132 - 132
  • [26] Effect of mulberry on the pharmacokinetics of cyclosporine, a probe drug of P-glycoprotein and CYP3A, in rats
    Hsu, Pei-Wen
    Tsai, Shang-Yuan
    Chao, Pei-Dawn Lee
    Hou, Yu-Chi
    DRUG METABOLISM REVIEWS, 2011, 43 : 34 - 34
  • [27] Alfentanil and fexofenadine combination to probe intestinal CYP3A and P-glycoprotein activities.
    Walker, A
    Hoffer, CJ
    Sheffels, P
    Kharasch, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P17 - P17
  • [28] Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues
    Matheny, CJ
    Ali, RY
    Yang, XD
    Pollack, GM
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (09) : 1008 - 1014
  • [29] Pregnancy Does Not Increase CYP3A or P-Glycoprotein Activity in the Non-Human Primate, Macaca nemestrina
    Zhang, Huixia
    Wu, Xiaohui
    Naraharisetti, Suresh Babu
    Chung, Francisco
    Whittington, Dale
    Mirfazaelian, Ahmad
    Unadkat, Jashvant D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (02): : 586 - 595
  • [30] Interactions of tamoxifen and metabolites with human CYP3A and P-glycoprotein.
    Bekaii-Saab, T
    Perloff, M
    Weemhoff, J
    von Moltke, L
    Greenblatt, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P11 - P11
12345